Jindal Medicare (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.48 M
as on 16-11-2024
- Company Age 21 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.80 M
as on 16-11-2024
- Revenue 78.37%
(FY 2023)
- Profit -34.34%
(FY 2023)
- Ebitda -35.07%
(FY 2023)
- Net Worth 1.12%
(FY 2023)
- Total Assets -8.08%
(FY 2023)
About Jindal Medicare (India)
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.48 M.
The company currently has active open charges totaling ₹1.80 M.
Sanjay Jindal, Mamata Jindal, Rishi Agrawal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85110CT2003PTC015922
- Company No.
015922
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jul 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Company Details
- Location
Raipur, Chattisgarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jindal Medicare (India)?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Jindal  | Director | 01-Jul-2003 | Current |
| Mamata Jindal | Director | 01-Jul-2003 | Current |
| Rishi Agrawal | Director | 18-Oct-2024 | Current |
| Kamal Yadav | Additional Director | 16-Jun-2023 | Current |
| Sunita Yadav | Director | 29-Mar-2024 | Current |
Financial Performance of Jindal Medicare (India).
Jindal Medicare (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 78.37% increase. The company also saw a substantial fall in profitability, with a 34.34% decrease in profit. The company's net worth moved up by a moderate rise of 1.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jindal Medicare (India)?
In 2023, Jindal Medicare (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sahaj Clinics And Hospital Private LimitedActive 4 years 4 months
Sanjay Jindal and Mamata Jindal are mutual person
- Pragya Greenland And Investment Private LimitedActive 16 years 4 months
Rishi Agrawal is a mutual person
- Aarogya Hospital And Research Centre Private LimitedActive 15 years 9 months
Rishi Agrawal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 May 2024 | ₹1.80 M | Open |
How Many Employees Work at Jindal Medicare (India)?
Unlock and access historical data on people associated with Jindal Medicare (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jindal Medicare (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jindal Medicare (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
